29th May 2025

A 65-year-old man with longstanding T2DM and a history of cardiovascular disease is currently managed with multiple antidiabetic agents, including insulin.

A 65-year-old man with longstanding T2DM and a history of cardiovascular disease is currently managed with multiple antidiabetic agents, including insulin. His HbA1c has been stable at 55 mmol/mol. Despite optimal medical therapy, he experiences frequent hypoglycaemic episodes. What advanced monitoring strategy should be considered for this patient?

Select the SINGLE most appropriate option from the list below. Select ONE option only.